Biolife Solutions (BLFS) Long-Term Investments (2016 - 2026)

Biolife Solutions (BLFS) has reported Long-Term Investments for 11 consecutive years, with $30.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Long-Term Investments rose 60.06% year-over-year to $30.5 million; the TTM figure through Mar 2026 stood at $30.5 million (up 60.06% YoY), while the FY2025 annual figure was $31.2 million, up 3040.7% from the prior year.
• Long-Term Investments retreated to $30.5 million in Q1 2026 per BLFS's latest filing, from $31.2 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $31.2 million in Q4 2025 and bottomed at $489000.0 in Q2 2022.
• Historically, Long-Term Investments has averaged $8.3 million across 5 years, with a median of $1.8 million in 2023.
• Annual changes were most pronounced in 2022 — Long-Term Investments sank 91.67% — and 2025, when it jumped 3040.7%.
• Biolife Solutions' Long-Term Investments stood at $5.1 million in 2022, then plunged by 89.19% to $548000.0 in 2023, then surged by 81.57% to $995000.0 in 2024, then surged by 3040.7% to $31.2 million in 2025, then retreated by 2.4% to $30.5 million in 2026.
• Business Quant data shows BLFS's Long-Term Investments at $30.5 million in Q1 2026, $31.2 million in Q4 2025, and $19.4 million in Q3 2025.